Grupo para la caracterización molecular de las neoplasias hematológicas
Azienda Ospedaliero-Universitaria Careggi
Florencia, ItaliaPublications en collaboration avec des chercheurs de Azienda Ospedaliero-Universitaria Careggi (2)
2023
-
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
The Lancet, Vol. 401, Núm. 10373, pp. 269-280
2018
-
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study
Haematologica, Vol. 103, Núm. 7, pp. 1209-1217